Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on May 5, 2017, detailing the outcomes of its 2017 annual meeting of stockholders and an authorized increase to its share repurchase program. The annual meeting, held on May 3, 2017, saw all proposals pass, including the election of three Class II directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and advisory votes to approve executive compensation and its frequency. The overwhelming approval for electing directors and ratifying the auditor indicates strong shareholder confidence in the company's governance and financial oversight.
Key Highlights
- 1IDEXX Laboratories held its 2017 annual meeting of stockholders on May 3, 2017, with a quorum present.
- 2Stockholders re-elected Rebecca M. Henderson, PhD, Lawrence D. Kingsley, and Sophie V. Vandebroek, PhD as Class II directors.
- 3The appointment of PricewaterhouseCoopers LLP as the independent registered accounting firm for the fiscal year was ratified with overwhelming support.
- 4An advisory vote to approve the compensation of named executive officers passed, with a majority of shareholders voting in favor.
- 5Shareholders also approved, on an advisory basis, seeking an advisory vote on executive compensation annually.
- 6On May 2, 2017, the Board of Directors authorized an increase to the share repurchase program, adding authorization for up to three million additional shares.
- 7This increase brings the total authorized shares for repurchase to sixty-eight million.